Hemrajani Rekha
Insider CIK 1771213 · MXCT Director · ADVM Director · ARAV President and CEO, Director · LBRX Director · BIOA Director · RCUS See Remarks · ALXO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MXCT MAXCYTE, INC. | A Award deriv | 2026-06-17 | 2026-06-22 | 49,579 | — | $0 | 49,579 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2026-06-17 | 2026-06-22 | 30,421 | — | $0 | 70,314 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 22,000 | — | $0 | 22,000 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2026-06-03 | 2026-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2026-01-20 | 2026-01-21 | 40,400 | — | $0 | 40,400 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2025-09-10 | 2025-09-12 | 22,449 | — | $0 | 22,449 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2025-06-25 | 2025-08-27 | 10,684 | $2.09 | $22.3K | 39,893 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 50,790 | — | $0 | 50,790 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2025-06-18 | 2025-06-23 | 29,210 | — | $0 | 50,577 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-01-21 | 2025-01-23 | 40,400 | — | $0 | 40,400 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2024-12-02 | 2024-12-04 | 30,000 | $1.55 | $46.5K | 33,000 | SEC↗ |
| BIOA BioAge Labs, Inc. | P Buy | 2024-09-27 | 2025-03-10 | 3,000 | $18.00 | $54.0K | 3,000 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2024-09-25 | 2024-09-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2024-06-13 | 2024-06-14 | 20,200 | — | $0 | 20,200 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2024-06-11 | 2024-06-13 | 40,701 | — | $0 | 40,701 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2024-06-11 | 2024-06-13 | 21,367 | — | $0 | 21,367 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2024-04-17 | 2024-09-27 | 28,497 | — | $0 | 28,497 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2023-06-22 | 2023-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2023-06-20 | 2023-06-22 | 20,200 | — | $0 | 20,200 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2023-03-20 | 2023-03-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2022-06-29 | 2022-07-08 | 26,900 | — | $0 | 26,900 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2022-06-15 | 2022-06-16 | 12,004 | — | $0 | 12,004 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2021-08-09 | 2021-08-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2021-06-11 | 2021-06-15 | 12,004 | — | $0 | 12,004 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 3,000 | $19.00 | $57.0K | 3,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-06-23 | 2020-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ARAV Aravive, Inc. | D To issuer | 2020-04-08 | 2020-04-09 | 42,750 | — | $0 | 14,250 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-01-09 | 2020-01-09 | 143,000 | — | $0 | 143,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award | 2020-01-09 | 2020-01-09 | 57,000 | — | $0 | 57,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-08-15 | 2019-08-16 | 33,750 | — | $0 | 45,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-07-31 | 2019-08-02 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-05-01 | 2019-05-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2019-03-25 | 2019-03-25 | 400,000 | — | $0 | 400,000 | SEC↗ |